The study on protective effect of α7 nicotinic antagonist on PC12 cell injury induced by β-Amyloid peptides.

WANG Zhigang,QI Renbin,LI Wei,ZHANG J,ZHAO Yanru,ZHU Lihong,LU Daxiang

2011-01-01

Abstract:Objective To observe the long term effect of chronic administration of α7 nicotinic antagonist on PC12 cells injury induced by β-Amyloid peptides.Methods Well-differentiated PC12 cells were exposed to Aβ25-35 to create PC12 cell injury model and nicotine and methyllycaconitine were administrated before PC12 cell injury.The experimental groups were divided as follows:control(Distilled Water),model group(Aβ25-35),nicotine group(nicotine and Aβ25-35) and methyllycaconitine group(methyllycaconitine and Aβ25-35).The cellar viability was detected using MTT chromatometry and the apoptosis and necrosis was detected by flow cytometer.Results Compared with control group,the cellular viability was decreased and apoptotic and necrotic rates were increased at every phase in model group(P < 0.01).Compared with model and methyllycaconitine groups,the cellular viability was increased(P < 0.05) and apoptotic and necrotic rate were decreased in nicotine group(P < 0.01) between 36 and 60 h following treatment.There were no significant changes in cellular viability and apoptotic as well as necrotic rates between model and methyllycaconitine groups between 36 to 60 h following treatment.When treatment was prolonged to 48 h,there were no significant differences in cellular viability and apoptotic as well as necrotic rates between nicotine and model groups.However,treatment with Methyllycaconitine for 48 h significantly increased cell viability and decreased apoptotic and necrotic rates compared with either model or nicotine groups(P < 0.01).Conclusions When treatment is prolonged,the protective effect of nicotinic agonist(nicotine) decreases whereas the protective effect of α7 nicotinic antagonist(methyllycaconitine) increases.